Dupixent Lymphoma Lawsuit Alleges Atopic Dermatitis Drug Led to Mycosis Fungoides Diagnosis

As of 2026-08-21, the Dupixent Lymphoma Lawsuit Alleges Atopic Dermatitis Drug Led to Mycosis Fungoides Diagnosis is open. You can check whether you qualify with the free 1-minute eligibility self-check below.

Last verified: 2026-08-21

Am I eligible for the Dupixent Lymphoma Lawsuit Alleges Atopic Dermatitis Drug Led to Mycosis Fungoides Diagnosis?

A California woman's Dupixent lymphoma lawsuit claims the manufacturers knew of the eczema drug's cancer risks, but refused to inform doctors and patients.

How do I join the Dupixent Lymphoma Lawsuit Alleges Atopic Dermatitis Drug Led to Mycosis Fungoides Diagnosis?

1. Run the free 1-minute eligibility self-check.
2. If you qualify, register your claim on the platform.
3. Class members typically pay nothing unless money is recovered.

Other active class actions

• Inferior Vena Cava IVC Filter Class Action
• Johnson and Johnson Ovarian Cancer Class Action
• 911 Fees Class Action
• Barrick Pascua-Lama Class Action
• Bernzomatic Gas Torch Defect Class Action
• Canadian Standards Association/Standards Council of Canada Class Actio
• Chevy & Cadillac Defective Transmissions – GM Class Action Canada
• Chrysler Ignition Class Action
• Dodge Chrysler Tire Sensor Defect Class Action
• Eliquis Class Action
• Essure Permanent Birth Control Class Action
• Fiat Chrysler Diesel Emissions Class Action

← Browse all 3771+ class actions

This is a free eligibility self-check, not a law firm, not legal advice, and not a lawyer referral service. Using it does not create a lawyer-client relationship.